Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4
- 1 November 2000
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 111 (1-2) , 86-92
- https://doi.org/10.1016/s0165-5728(00)00377-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patientsJournal of Neuroimmunology, 2000
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and FunctionAnnual Review of Immunology, 1997
- Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ)Current Opinion in Immunology, 1997
- Functional diversity of helper T lymphocytesNature, 1996
- Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations.The Journal of Experimental Medicine, 1995
- Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?Acta Neurologica Scandinavica, 1988
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONPublished by Elsevier ,1987
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983